Table 4.
Median OS as calculated from the end of treatment (immunotherapy or radiation) or decision to start immunotherapy.
Endpoint for OS | Immunotherapy Timing | Median OS from SBRT (months) | p-value |
---|---|---|---|
End of treatment | Before | 3.088 | 0.064 |
Concurrent/After | 9.331 | ||
Decision to start immunotherapy | Before | 10.02 | 0.91 |
Concurrent/After | 12.65 |
OS, Overall survival; SBRT, Stereotactic Body Radiotherapy.